SCIN and central nervous system cancer: To gain further insight into SCIN and MMP2/9 changes that arise in glioma progression, TMA was made through our clinical specimens in our study, including 106 glioma tissues and 10 normal brain tissues, and the detailed clinicopathological characteristic data of the glioma patients are shown in Table 1.